Balansag, Rodelia B.
HRN: 08-69-08 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/15/2025
09/22/2025
IV
4.5gm
Q6h
Diabetic Food-none Healing Wound
Checking Initial Appropriateness
09/16/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/16/2025
09/22/2025
IV
600mg
Q8
Infected Wound
Checking Initial Appropriateness
09/16/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/16/2025
09/22/2025
IV
2.25gm
Q8
Infected Wound
Checking Initial Appropriateness